4.6 Review

The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis

期刊

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
卷 31, 期 9, 页码 809-819

出版社

SPRINGER
DOI: 10.1007/BF03349262

关键词

Cancer stem cells; chemokines; CXCR4; SDF-1; metastasis

向作者/读者索取更多资源

Chemokines exert their multifunctional role in several physiologic and pathologic processes through interaction with their specific receptors. Much evidence have revealed that metastatic spread tumor cells may use chemokine-mediated mechanisms. In particular, an involvement of stromal cell-derived factor-1 (SDF-1) in growth of primary tumors and in metastatic process has been demonstrated. Indeed, it has been suggested that CXCR4 expression by tumor cells, plays a critical role in cell metastasis by a chemotactic gradient to organs expressing the ligand SDF-1. Moreover, CXCR4 overexpression correlated with poor prognosis in many types of cancer. In physiologic condition, SDF-1 also plays an essential role modulating stem cell proliferation, survival, and homing through its canonical receptor CXCR4. Recently, several studies have demonstrated the existence of a small subset of cancer cells which share many characteristics with stem cells and named cancer stem cells (CSC). They constitute a reservoir of self-sustaining cells with the ability to maintain the tumor growth. In particular, most of them express CXCR4 receptor and respond to a chemotactic gradient of its specific ligand SDF-1, suggesting that CSC probably represent a subpopulation capable of initiating metastasis. This review focuses on the role of SDF-1/CXCR4 axis in cancer and in the metastatic progression by tumoral cells, as well as the role of CSC in tumor pathogenesis and in metastatic process. A better understanding of migratory mechanism involving cancer cells and CSC provides a powerful tool for developing novel therapies reducing both local and distant recurrences.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Transplantation

Mechanisms and trade-offs of kidney repair: consequences for the nephrology clinician

Paola Romagnani

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Review Transplantation

SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease, 'diabetic nephropathy', IgA nephropathy and podocytopathies with FSGS lesions

Hans-Joachim Anders, Anna Julie Peired, Paola Romagnani

Summary: The DAPA-CKD trial demonstrated that the SGLT2 inhibitor, dapagliflozin, attenuates the progression of chronic kidney disease (CKD) with proteinuria in patients with or without diabetes. This has significant implications for the understanding and treatment of CKD, suggesting that SGLT2 inhibition should be a central component in CKD management regardless of diabetes status. It may also impact the treatment approaches for IgA nephropathy and focal segmental glomerulosclerosis.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Review Urology & Nephrology

Nephron overload as a therapeutic target to maximize kidney lifespan

Valerie A. Luyckx, Andrew D. Rule, Katherine R. Tuttle, Pierre Delanaye, Helen Liapis, Afschin Gandjour, Paola Romagnani, Hans-Joachim Anders

Summary: This article highlights the importance of kidney lifespan in understanding chronic kidney disease. Adaptive adjustments of nephrons are crucial for maintaining kidney function and structure, and the progression of kidney disease due to nephron loss is closely related to individual kidney function status.

NATURE REVIEWS NEPHROLOGY (2022)

Review Biochemistry & Molecular Biology

Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI

Letizia De Chiara, Gianmarco Lugli, Gianluca Villa, Valentina Raglianti, Faeq Husain-Syed, Fiammetta Ravaglia, Paola Romagnani, Elena Lazzeri

Summary: This review discusses the mechanisms of chemotherapy-induced acute kidney injury, available biomarkers for early detection, and raises awareness of chemotherapy-induced acute kidney injury.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Pediatrics

Expectations in children with glomerular diseases from SGLT2 inhibitors

Luigi Cirillo, Fiammetta Ravaglia, Carmela Errichiello, Hans-Joachim Anders, Paola Romagnani, Francesca Becherucci

Summary: Chronic kidney disease (CKD) is a global public healthcare concern in the pediatric population, with glomerulopathies being the second most common cause. Sodium-glucose transporter 2 inhibitors (SGLT2i) show promise in slowing the progression of CKD and glomerular diseases in children, although their use in this population is not yet approved.

PEDIATRIC NEPHROLOGY (2022)

Letter Immunology

Response to Third Dose of Vaccine Against SARS-CoV-2 in Adolescent and Young Adult Kidney Transplant Recipients

Luigi Cirillo, Francesco Citera, Tommaso Mazzierli, Francesca Becherucci, Vito Terlizzi, Lorenzo Lodi, Elisa Buti, Paola Romagnani

TRANSPLANTATION (2022)

Review Cell Biology

The Pathology Lesion Patterns of Podocytopathies: How and why?

Fiammetta Ravaglia, Maria Elena Melica, Maria Lucia Angelotti, Letizia De Chiara, Paola Romagnani, Laura Lasagni

Summary: Podocytopathies are a group of proteinuric glomerular disorders driven by primary podocyte injury, with various lesion patterns observed on kidney biopsy. Recent evidence suggests that these patterns represent signs of repeated injury and repair attempts, depending on the type, length, and severity of the podocyte injury, as well as the ability of parietal epithelial cells to drive repair processes.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Urology & Nephrology

A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon

Giorgio Trivioli, Elena Gelain, Maria L. Angelotti, Fiammetta Ravaglia, Marco Allinovi, Lorenzo Lodi, Leonardo Caroti, Annamaria Buccoliero, Giacomo Emmi, Marco Gattorno, Paola Romagnani, Stefano Volpi, Augusto Vaglio

Summary: ADA2 deficiency is a rare genetic disease that can cause various kidney manifestations and may be associated with type I interferon.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Article Immunology

DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling

Maud Tusseau, Ema Lovsin, Charlotte Samaille, Remi Pescarmona, Anne-Laure Mathieu, Maria-Cristina Maggio, Velma Selmanovic, Marusa Debeljak, Angelique Dachy, Gregor Novljan, Alexandre Janin, Louis Januel, Jean-Baptiste Gibier, Emilie Chopin, Isabelle Rouvet, David Goncalves, Nicole Fabien, Gillian Rice, Gaetan Lesca, Audrey Labalme, Paola Romagnani, Thierry Walzer, Sebastien Viel, Magali Perret, Yanick J. Crow, Tadej Avcin, Rolando Cimaz, Alexandre Belot

Summary: The interferon signaling in DNASE1L3 deficient patients is transient, unlike the anomalies observed in other diseases. DNASE1L3 deficiencies are associated with a broad phenotype including lupus nephritis and hypocomplementemic urticarial vasculitis.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Article Cell Biology

Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice

Maria Elena Melica, Giulia Antonelli, Roberto Semeraro, Maria Lucia Angelotti, Gianmarco Lugli, Samuela Landini, Fiammetta Ravaglia, Gilda La Regina, Carolina Conte, Letizia De Chiara, Anna Julie Peired, Benedetta Mazzinghi, Marta Donati, Alice Molli, Stefanie Steiger, Alberto Magi, Niccolo Bartalucci, Valentina Raglianti, Francesco Guzzi, Laura Maggi, Francesco Annunziato, Alexa Burger, Elena Lazzeri, Hans-Joachim Anders, Laura Lasagni, Paola Romagnani

Summary: Crescentic glomerulonephritis is a disease characterized by vascular necrosis and hyperplasia of epithelial cells, resulting in the formation of crescents. Little is known about the molecular mechanisms driving this process. Research on mouse models showed that crescents are derived from the clonal expansion of immature parietal epithelial cells. Treatment with panobinostat, a histone deacetylase inhibitor, attenuated crescentic glomerulonephritis and restored kidney function by inducing differentiation of immature hyperplastic parietal epithelial cells into podocytes.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Transplantation

Intravenous Glu-plasminogen attenuates cholesterol crystal embolism-induced thrombotic angiopathy, acute kidney injury and kidney infarction

Lyuben Lyubenov, Chongxu Shi, Danyang Zhao, Luying Yang, Yutian Lei, Elmina Mammadova-Bach, Letizia de Chiara, Roberto Semeraro, Samuela Landini, Paola Romagnani, Elena Voerg, Satish K. Devarapu, Ricarda Welz, Stephan T. Kiessig, Hans-Joachim Anders

Summary: Cholesterol crystal (CC) embolism leads to acute kidney injury (AKI) and ischaemic cortical necrosis with high mortality. Injection of Glu-plasminogen (Glu-Plg) showed a dose-dependent attenuation of thrombotic angiopathy, GFR loss, and ischaemic necrosis in mice with CC embolism. Intermediate dose of Glu-Plg had transient protective effect, while high dose provided full protection without bleeding complications.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Review Biochemistry & Molecular Biology

Role of Sex Hormones in Prevalent Kidney Diseases

Carolina Conte, Giulia Antonelli, Maria Elena Melica, Mirko Tarocchi, Paola Romagnani, Anna Julie Peired

Summary: Chronic kidney disease (CKD) is a global health burden affecting over 840 million people worldwide. It presents sex disparities in its pathophysiology, epidemiology, clinical manifestations, and disease progression. While CKD is more frequent in females, males have a higher risk of progressing to end-stage kidney disease. Recent studies have highlighted the role of sex hormones in the development and progression of CKD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Transplantation

The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC)

Paola Romagnani, A. Richard Kitching, Nelson Leung, Hans-Joachim Anders

Summary: Glomerulonephritis (GN) is a diverse group of immune-mediated disorders, which cannot be properly classified or treated based on histological patterns alone. To overcome this problem, a new classification system is proposed that considers disease category, immunological activity, and chronicity, which will guide the therapeutic approach.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Biochemistry & Molecular Biology

Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy

Marco Allinovi, Francesco Sessa, Gianluca Villa, Andrea Cocci, Samantha Innocenti, Maria Zanazzi, Lorenzo Tofani, Laura Paparella, Dritan Curi, Calogero Lino Cirami, Riccardo Campi, Andrea Mari, Agostino Ognibene, Maria Lorubbio, Alessandra Fanelli, Stefano Romagnoli, Paola Romagnani, Andrea Minervini

Summary: The study aimed to identify and compare serum and urinary predictors for predicting long-term decline in glomerular filtration rate (GFR) after robotic Nephron-Spearing Surgery (rNSS). The results showed that patients who developed clinical acute kidney injury (AKI) had a more pronounced decline in eGFR at 24 months. KineticGFR at 4 hours and NephroCheck at 10 hours were found to be efficient predictors of post-operative AKI and long-term eGFR decline. Combining these biomarkers could help identify high-risk patients as early as 10 hours after surgery.

BIOMEDICINES (2023)

Article Urology & Nephrology

Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3(-/-) Mice

Zhihui Zhu, Karoline A. T. Rosenkranz, Yoshihiro Kusunoki, Chenyu Li, Martin Klaus, Oliver Gross, Maria-Lucia Angelotti, Giulia Antonelli, Luigi Cirillo, Paola Romagnani, Nassim Bouteldja, Alireza Vafaei Sadr, Roman D. Buelow, Peter Boor, Hans-Joachim Anders

Summary: A preclinical study in mice suggests that triple blockade of RAS/SGLT2/MR may significantly improve renal outcomes in Alport syndrome and other progressive CKDs due to synergistic effects on the glomerular and tubulointerstitial compartments.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

暂无数据